Unlock instant, AI-driven research and patent intelligence for your innovation.

Antibody fragment of DNA polymerase, antibody and application thereof

A technology of antibody fragments and polymerases, applied in the fields of application, anti-enzyme immunoglobulin, biochemical equipment and methods, etc., can solve problems such as complicated use process and application limitations, and achieve high affinity effect

Active Publication Date: 2020-03-13
SHENZHEN HUADA GENE INST
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, there is no hot-start antibody against pfu DNA polymerase at present. In the normal PCR process, it can only be hot-started by physical methods, which makes the use process complicated and the application is limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody fragment of DNA polymerase, antibody and application thereof
  • Antibody fragment of DNA polymerase, antibody and application thereof
  • Antibody fragment of DNA polymerase, antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0085] Example 2 cell fusion

[0086] 1. Preparation of Myeloma Cells

[0087] In this example, SP2 / 0Ag14 myeloma cells were used. The cells were cultured to a good growth state and good shape. Before fusion, the cells were cultured to the logarithmic growth phase, and suspended to prepare a suspension with a certain cell density.

[0088] 2. Preparation of Splenocytes

[0089] Several mice with the highest titers were selected and sacrificed. Fix the dissecting board, take out the spleen, put it in fresh medium, remove the adhesive tissue, grind the spleen, filter it with a 200-mesh drying net, add red blood cell lysate to lyse for 10 minutes after washing, add fresh medium to dilute, centrifuge to remove the supernatant, and re- Dissolve in the medium, measure the cell density, and dilute the cells to a certain concentration.

[0090] 3. Cell Fusion

[0091] Mix the above SP2 / 0Ag14 cells and splenocytes at a ratio of 1:10, then add polyethylene glycol 2000 (PEG2000) for ...

Embodiment 3

[0092] Embodiment 3 hybridoma subcloning screening

[0093] After the hybridoma cells in the 96-well plate in Example 2 were cultured for 2 weeks, the supernatant was taken for ELISA to identify the positive value of the antibody in the supernatant. Positive cell lines were screened for the second round of limited dilution subcloning. ELISA was then used to identify and screen positive cell lines. The ELISA screening process is as follows:

[0094] (1) Coat 100 μl of antigen (DNA polymerase concentration 1 μg / ml) on the enzyme strip overnight. Add 200 μl PBST and shake for 10 min, wash 3 times, and wash with PBS 3 times.

[0095] (2) Add 200 μl of 1% BSA-PBS and block at 37° C. for 2 hours. PBST 200μl, 10min, wash 3 times, PBS 200μl, 10min, wash 3 times.

[0096] (3) Add 100 μl of the diluted supernatant, and incubate at 37° C. for 2 hours. PBST 200μl, 10min, wash 3 times, PBS 200μl, 10min, wash 3 times.

[0097] (4) Add 100 μl of diluted commercial horseradish peroxida...

Embodiment 4

[0104] Example 4 Monoclonal Antibody Preparation and Neutralizing Activity Screening

[0105] The above-mentioned positive hybridoma cell lines were expanded and cultured. The supernatant was collected, centrifuged at 8000rpm for 15min, filtered through a 0.22μm filter membrane, purified with a protein A (protein A) column, and eluted with an eluent to obtain a purified monoclonal antibody. Monoclonal antibodies were screened using polymerase polymerization activity assays. Finally, the monoclonal antibody capable of inhibiting the polymerization activity of DNA polymerase was obtained through screening. The screening experiment of monoclonal antibody inhibiting polymerase activity is as follows:

[0106] (1) Mix the monoclonal antibody and DNA polymerase at a molecular ratio of 1:1, and incubate at room temperature for 2 hours.

[0107] (2) react according to the system of table 3:

[0108] table 3

[0109]

[0110] React at 37°C for 2 hours.

[0111] The double-stra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an antibody fragment of DNA polymerase, an antibody and an application of the antibody fragment. The antibody comprises a heavy-chain variable region amino acid sequence witha sequence shown in any one of SEQ ID NO: 1-3; and a light-chain variable region amino acid sequence with the sequence shown in any one of SEQ ID NO: 7-9. The monoclonal antibody of the DNA polymeraseprovided by the invention has the characteristic of high affinity with the antigen DNA polymerase, and can specifically neutralize the polymerization of the DNA polymerase.

Description

technical field [0001] The invention relates to the technical field of antibodies, in particular to an antibody fragment of a DNA polymerase, an antibody and applications thereof. Background technique [0002] In 1956, A. Kornberg first discovered Escherichia coli DNA polymerase I. From then on, the development and application of DNA polymerase began. Among them, thermostable DNA polymerase is most widely used in PCR technology. However, when DNA polymerase is used in PCR, its enzymatic activity remains before the thermal denaturation step, resulting in non-specific amplification of PCR, resulting in reduced sensitivity and yield of the reaction. Therefore, it is necessary to find ways to reduce adverse reactions. [0003] Several methods currently in use include physical isolation, chemical modification, and hot-start antibody methods. Among them, the most widely used and effective method is the hot start antibody method. Hot start products currently in use include taq...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/40C12N15/13G01N33/573
CPCC07K16/40C07K2317/92G01N33/573
Inventor 王佑富李静郑越刘芬董宇亮章文蔚徐崇钧
Owner SHENZHEN HUADA GENE INST